Ocular Trauma and COVID-19 in Indonesia

Ocular injuries, a significant contributor to avoidable blindness globally, impact approximately 55 million individuals each year. Prompt initial treatment is vital for improving vision, yet the scarcity of skilled eye specialists often results in overcrowding at advanced medical centers. Moreover, the COVID-19 outbreak has introduced distinct factors into the management of ocular trauma. This research investigated the epidemiology of ocular injuries during the pandemic and offered observations on the distinctive hurdles and trends encountered.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ophthalmological Disorder COVID-19 Coronaviridae Infections Coronavirus Infections Craniocerebral Trauma Eye Diseases Eye Injuries Facial Injuries Infections Lung Diseases Nervous System Diseases Nidovirales Infections Ocular Injury Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Trauma, Nervous System Virus Diseases Wounds and Injuries

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Ophthalmology, Prof. R. D. Kandou General Hospital - Faculty of Medicine, Sam Ratulangi University

Manado, North Sulawesi, Indonesia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Ocular Trauma Patients presenting between January 2021 to March 2022

Exclusion criteria

Presenting on days outside the inclusion criteria

Treatment and study plan

Primary outcomes

Ocular Trauma

Time frame: 2 weeks

Sponsors and collaborators

Lead sponsor

Prof. R. D. Kandou General Hospital

Other

Registry information

Official study title

Ocular Trauma During the COVID-19 Pandemic Era at an Indonesian Tertiary Care Center: A Retrospective Cohort Study

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2023
First posted: Mar 4, 2024
Registry last updated: Mar 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed